IDEX Corp executive exercises options and sells shares

Rhea-AI Filing Summary

IDEX Corp senior executive Lisa M. Anderson, SVP, GC, CAO & Corporate Secretary, exercised options to acquire 385 shares of common stock at an exercise price of $93.27 per share, originally granted with an exercise date of February 22, 2018 and expiring February 22, 2027. On the same day, she sold 385 shares of common stock at a weighted average price of $238.5949 per share, with individual trade prices ranging from $238.39 to $238.73. Following the transaction, the reported option position of 385 options was reduced to 0.

Insider Trade Summary

Exercise and Sale: 385 shares ($56K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Anderson Lisa M

Role SVP, GC, CAO & Corp Sec

Sold 385 shs ($92K)

Approx. gross sale proceeds $92K

Approx. exercise cost $36K

Approx. pre-tax spread $56K

Type	Security	Shares	Price	Value
Exercise	OPTIONS (RIGHT TO BUY)	385	$0.00	$0.00
Exercise	COMMON STOCK	385	$93.27	$36K
Sale	COMMON STOCK F1	385	$238.5949	$92K

Holdings After Transaction: OPTIONS (RIGHT TO BUY) — 0 contracts (Direct); COMMON STOCK — 4,327 shares (Direct)

Footnotes (1)

1. F1. The transaction was executed in multiple trades at prices ranging from $238.39 to $238.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 1 of this Form 4.

Key Figures

Shares exercised: 385 shares Option exercise price: $93.27 per share Weighted average sale price: $238.5949 per share +3 more

6 metrics

Shares exercised 385 shares Options exercised into common stock on August 12, 2026

Option exercise price $93.27 per share Exercise price of options granted on February 22, 2018

Weighted average sale price $238.5949 per share Common stock sold on August 12, 2026

Sale price range $238.39–$238.73 per share Price range of multiple trades in the reported sale

Options after transaction 0 options Options (Right to Buy) position following the 385-share exercise

Option expiration date February 22, 2027 Expiration of the exercised options grant

Key Terms

Options (Right to Buy), derivative security, weighted average sale price, multiple trades

4 terms

Options (Right to Buy) financial

"security_title: "OPTIONS (RIGHT TO BUY)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

weighted average sale price financial

"The price reported in Column 4 above reflects the weighted average sale price."

multiple trades financial

"The transaction was executed in multiple trades at prices ranging"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IDEX (IEX) executive Lisa M. Anderson report in this Form 4?

Lisa M. Anderson reported exercising options for 385 IDEX shares at $93.27 each and selling 385 common shares on August 12, 2026 at a weighted average price of $238.5949 per share.

How many IDEX (IEX) shares did the insider sell and at what price?

The insider sold 385 shares of IDEX common stock at a weighted average price of $238.5949 per share, with trades executed in a price range of $238.39 to $238.73 on August 12, 2026.

What options did the IDEX (IEX) executive exercise in this transaction?

The executive exercised 385 options to buy IDEX common stock at an exercise price of $93.27 per share. These options had an exercise date of February 22, 2018 and an expiration date of February 22, 2027.

Did the IDEX (IEX) insider retain any of the shares from the option exercise?

Based on this report, the insider sold 385 common shares after exercising options for the same number of shares, indicating this filing reflects an exercise-and-sell sequence for the 385 shares involved.

What position does the reporting person hold at IDEX (IEX)?

The reporting person, Lisa M. Anderson, serves as Senior Vice President, General Counsel, Chief Administrative Officer and Corporate Secretary of IDEX, indicating a key executive and legal leadership role at the company.

Were the IDEX (IEX) option holdings affected by this transaction?

Yes. The filing shows the options position of 385 options used in this transaction was reduced to 0 following the exercise, meaning this specific option grant no longer remains outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 06:06 PM Accepted by SEC EDGAR 08/13/2026 - 06:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Lisa M

(Last) (First) (Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK ILLINOIS 60062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC, CAO & Corp Sec

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	08/12/2026		M		385	A	$93.27	4,712	D
COMMON STOCK	08/12/2026		S		385	D	$238.5949(1)	4,327	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OPTIONS (RIGHT TO BUY)	$93.27	08/12/2026		M			385	02/22/2018	02/22/2027	COMMON STOCK	385	$0	0	D

Explanation of Responses:

1. The transaction was executed in multiple trades at prices ranging from $238.39 to $238.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 1 of this Form 4.

	/s/ Sam Rayburn, by Power of Attorney	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)